1. Home
  2. PD vs BBIO Comparison

PD vs BBIO Comparison

Compare PD & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PD
  • BBIO
  • Stock Information
  • Founded
  • PD 2009
  • BBIO 2015
  • Country
  • PD United States
  • BBIO United States
  • Employees
  • PD N/A
  • BBIO N/A
  • Industry
  • PD Computer Software: Prepackaged Software
  • BBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PD Technology
  • BBIO Health Care
  • Exchange
  • PD Nasdaq
  • BBIO Nasdaq
  • Market Cap
  • PD 1.5B
  • BBIO 9.4B
  • IPO Year
  • PD 2019
  • BBIO 2019
  • Fundamental
  • Price
  • PD $15.96
  • BBIO $51.18
  • Analyst Decision
  • PD Hold
  • BBIO Strong Buy
  • Analyst Count
  • PD 9
  • BBIO 16
  • Target Price
  • PD $18.33
  • BBIO $64.44
  • AVG Volume (30 Days)
  • PD 2.6M
  • BBIO 2.1M
  • Earning Date
  • PD 09-03-2025
  • BBIO 11-11-2025
  • Dividend Yield
  • PD N/A
  • BBIO N/A
  • EPS Growth
  • PD N/A
  • BBIO N/A
  • EPS
  • PD N/A
  • BBIO N/A
  • Revenue
  • PD $483,608,000.00
  • BBIO $235,812,000.00
  • Revenue This Year
  • PD $9.50
  • BBIO $115.97
  • Revenue Next Year
  • PD $7.41
  • BBIO $65.50
  • P/E Ratio
  • PD N/A
  • BBIO N/A
  • Revenue Growth
  • PD 8.20
  • BBIO 7.62
  • 52 Week Low
  • PD $13.70
  • BBIO $21.72
  • 52 Week High
  • PD $21.98
  • BBIO $54.60
  • Technical
  • Relative Strength Index (RSI)
  • PD 47.88
  • BBIO 52.52
  • Support Level
  • PD $15.74
  • BBIO $49.94
  • Resistance Level
  • PD $16.68
  • BBIO $54.29
  • Average True Range (ATR)
  • PD 0.80
  • BBIO 2.14
  • MACD
  • PD -0.09
  • BBIO -0.28
  • Stochastic Oscillator
  • PD 53.81
  • BBIO 35.71

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: